{
    "2018-03-05": [
        [
            {
                "time": "",
                "original_text": "[强于大市评级]医药行业周报：聚焦子行业龙头 看好恒瑞医药、安科生物、美年健康等",
                "features": {
                    "keywords": [
                        "医药行业",
                        "子行业龙头",
                        "恒瑞医药",
                        "安科生物",
                        "美年健康"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业周观点：年报季临近 建议关注业绩分化 继续推荐OTC及医药流通细分板块",
                "features": {
                    "keywords": [
                        "医药行业",
                        "年报季",
                        "业绩分化",
                        "OTC",
                        "医药流通"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医疗保健：2018政府工作报告为医药行业发展定下良好基调 荐8股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "政府工作报告",
                        "医药行业",
                        "良好基调"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【海通医药.3月月报】重点关注快报、一季报超预期个股",
                "features": {
                    "keywords": [
                        "海通医药",
                        "3月月报",
                        "快报",
                        "一季报",
                        "超预期个股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "“混改”成高频词，5大领域是重点",
                "features": {
                    "keywords": [
                        "混改",
                        "高频词",
                        "5大领域"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}